Published in Allergy on November 01, 2010
Prevalence of allergic sensitization in the United States: results from the National Health and Nutrition Examination Survey (NHANES) 2005-2006. J Allergy Clin Immunol (2014) 2.32
Tobacco smoke exposure and allergic sensitization in children: a propensity score analysis. Respirology (2012) 1.57
Invariant natural killer T cells recognize a fungal glycosphingolipid that can induce airway hyperreactivity. Nat Med (2013) 1.03
Prevalence and risk factors of childhood allergic diseases in eight metropolitan cities in China: a multicenter study. BMC Public Health (2011) 0.93
Alternaria alternata allergen Alt a 1: a unique β-barrel protein dimer found exclusively in fungi. J Allergy Clin Immunol (2012) 0.91
Association between allergies and risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev (2014) 0.89
Ambrosia artemisiifolia (ragweed) in Germany - current presence, allergological relevance and containment procedures. Allergo J Int (2015) 0.83
Exposure to Beta-(1,3)-D-glucan in house dust at age 7-10 is associated with airway hyperresponsiveness and atopic asthma by age 11-14. PLoS One (2014) 0.80
The efficacy and safety of the Timothy grass allergy sublingual immunotherapy tablet in Canadian adults and children. Allergy Asthma Clin Immunol (2014) 0.76
Efficacy and safety of ragweed sublingual immunotherapy in Canadian patients with allergic rhinoconjunctivitis. Allergy Asthma Clin Immunol (2014) 0.76
Pollen Allergens for Molecular Diagnosis. Curr Allergy Asthma Rep (2016) 0.75
Patterns of Inhalant Allergen Sensitization and Geographical Variation in Korean Adults: A Multicenter Retrospective Study. Allergy Asthma Immunol Res (2017) 0.75
The glutamate receptor ion channels. Pharmacol Rev (1999) 15.06
The use of beta-agonists and the risk of death and near death from asthma. N Engl J Med (1992) 8.53
Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med (1987) 8.41
Canadian Asthma Consensus Report, 1999. Canadian Asthma Consensus Group. CMAJ (1999) 7.05
Asbestos-related diseases of the lung and other organs: their epidemiology and implications for clinical practice. Am Rev Respir Dis (1976) 6.89
The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med (1995) 6.49
Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer. Thromb Haemost (2000) 4.81
Asthma mortality in New Zealand: a two year national study. N Z Med J (1985) 4.60
Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study. Am J Respir Crit Care Med (2001) 4.48
Mortality in COPD: Role of comorbidities. Eur Respir J (2006) 4.14
A comparison of active and simulated chiropractic manipulation as adjunctive treatment for childhood asthma. N Engl J Med (1998) 3.29
Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med (2000) 3.24
A new perspective on concepts of asthma severity and control. Eur Respir J (2008) 3.16
Control of GluR1 AMPA receptor function by cAMP-dependent protein kinase. J Neurosci (2000) 3.10
Prognosis in chronic obstructive pulmonary disease. Am Rev Respir Dis (1986) 3.03
International trends in asthma mortality: 1970 to 1985. Chest (1988) 2.97
Tumour necrosis factor and lymphotoxin A polymorphisms and lung function in smokers. Eur Respir J (2006) 2.85
Eosinophil-associated TGF-beta1 mRNA expression and airways fibrosis in bronchial asthma. Am J Respir Cell Mol Biol (1997) 2.84
Bronchodilators and acute cardiac death. Am J Respir Crit Care Med (1996) 2.80
Airways obstruction and the risk for lung cancer. Ann Intern Med (1987) 2.77
Mammalian Trithorax and polycomb-group homologues are antagonistic regulators of homeotic development. Proc Natl Acad Sci U S A (1999) 2.76
Accuracy of certification of deaths due to asthma. A national study. Am J Epidemiol (1986) 2.74
Methodological issues in therapeutic trials of COPD. Eur Respir J (2008) 2.69
Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease. Thorax (2005) 2.69
What is new since the last (1999) Canadian Asthma Consensus Guidelines? Can Respir J (2001) 2.65
Airway closure as a function of age. Respir Physiol (1969) 2.53
Effectiveness of the leukotriene receptor antagonist zafirlukast for mild-to-moderate asthma. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (1997) 2.52
Use of a clinical model for safe management of patients with suspected pulmonary embolism. Ann Intern Med (1998) 2.49
Canadian Thoracic Society Asthma Management Continuum--2010 Consensus Summary for children six years of age and over, and adults. Can Respir J (2010) 2.42
C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease. Thorax (2006) 2.38
The health of chrysotile asbestos mine and mill workers of Quebec. Arch Environ Health (1974) 2.34
Tuberculosis surveillance in immigrants to Manitoba. CMAJ (1990) 2.32
Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) study. Respir Med (2006) 2.29
Control of asthma in Canada: failure to achieve guideline targets. Can Respir J (2001) 2.26
Chronic obstructive pulmonary disease in the older adult: what defines abnormal lung function? Thorax (2006) 2.21
Increased morbidity and mortality related to asthma among asthmatic patients who use major tranquillisers. BMJ (1996) 2.20
Lung function in chrysotile asbestos mine and mill workers of Quebec. Arch Environ Health (1972) 2.18
Effects of cannabis on lung function: a population-based cohort study. Eur Respir J (2009) 2.16
Doubling the dose of budesonide versus maintenance treatment in asthma exacerbations. Thorax (2004) 2.13
A cohort analysis of excess mortality in asthma and the use of inhaled beta-agonists. Am J Respir Crit Care Med (1994) 2.11
Effects of an immunostimulating agent on acute exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease. The PARI-IS Study Steering Committee and Research Group. Prevention of Acute Respiratory Infection by an Immunostimulant. Am J Respir Crit Care Med (1997) 2.04
Susceptibility genes for rapid decline of lung function in the lung health study. Am J Respir Crit Care Med (2001) 2.03
Body weight in chronic obstructive pulmonary disease. The National Institutes of Health Intermittent Positive-Pressure Breathing Trial. Am Rev Respir Dis (1989) 2.03
Associations of IL6 polymorphisms with lung function decline and COPD. Thorax (2009) 2.00
The lymphoid transcription factor LyF-1 is encoded by specific, alternatively spliced mRNAs derived from the Ikaros gene. Mol Cell Biol (1994) 1.99
Risk factors for Alzheimer's disease: a population-based, longitudinal study in Manitoba, Canada. Int J Epidemiol (2001) 1.98
Respiratory symptoms in chrysotile asbestos mine and mill workers of Quebec. Arch Environ Health (1972) 1.94
Induced sputum cell counts in healthy adults. Am J Respir Crit Care Med (2000) 1.93
First treatment with inhaled corticosteroids and the prevention of admissions to hospital for asthma. Thorax (1998) 1.90
The respiratory effects of cannabis dependence in young adults. Addiction (2000) 1.89
Bronchodilator response in chronic obstructive pulmonary disease. Am Rev Respir Dis (1986) 1.87
A randomized controlled study on the effectiveness of a multifaceted intervention program in the primary prevention of asthma in high-risk infants. Arch Pediatr Adolesc Med (2000) 1.85
Prevalence of asthma, rhinitis and eczema among children in 2 Canadian cities: the International Study of Asthma and Allergies in Childhood. CMAJ (1999) 1.84
Formoterol as relief medication in asthma: a worldwide safety and effectiveness trial. Eur Respir J (2003) 1.84
Prevalence of exercise induced bronchospasm in Kenyan school children: an urban-rural comparison. Thorax (1998) 1.83
Regular use of inhaled corticosteroids and the long term prevention of hospitalisation for asthma. Thorax (2002) 1.81
Steroid response in stable chronic obstructive pulmonary disease. Ann Intern Med (1982) 1.80
Prevalence of bronchial reactivity to inhaled methacholine in New Zealand children. Thorax (1986) 1.76
Circulating fibronectin to C-reactive protein ratio and mortality: a biomarker in COPD? Eur Respir J (2008) 1.76
ProtSweep, 2Dsweep and DomainSweep: protein analysis suite at DKFZ. Nucleic Acids Res (2007) 1.72
Association of IL-1beta and IL-1 receptor antagonist haplotypes with rate of decline in lung function in smokers. Thorax (2001) 1.72
75 deaths in asthmatics prescribed home nebulisers. Br Med J (Clin Res Ed) (1987) 1.72
Where Manitoba children obtain their cigarettes. CMAJ (1987) 1.71
Radiological changes after withdrawal from asbestos exposure. Br J Ind Med (1979) 1.70
Regional lung function in patients with chronic bronchitis. Clin Sci (1968) 1.69
Asthma mortality: comparison between New Zealand and England. Br Med J (Clin Res Ed) (1986) 1.69
Induced sputum cell counts: their usefulness in clinical practice. Eur Respir J (2000) 1.69
Regional distribution of pulmonary ventilation and perfusion in obesity. J Clin Invest (1967) 1.68
Western red cedar dust exposure and lung function: a dose-response relationship. Am J Respir Crit Care Med (1996) 1.68
Effect of negative pressure ventilation in severe chronic obstructive pulmonary disease. Lancet (1992) 1.67
Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT SAA working party. Br J Haematol (1988) 1.66
The effect of age on risk factors for ischemic heart disease: the Manitoba Follow-Up Study, 1948-1993. Ann Epidemiol (1998) 1.66
Confounding by indication and channeling over time: the risks of beta 2-agonists. Am J Epidemiol (1996) 1.65
Identification of persons with cardiorespiratory conditions who are at risk of dying from the acute effects of ambient air particles. Environ Health Perspect (2001) 1.65
Exacerbations of asthma without sputum eosinophilia. Thorax (1995) 1.63
Chronic airflow limitation: its relationship to work in dusty occupations. Chest (1985) 1.61
Socioeconomic status and indicators of asthma in children. Am J Respir Crit Care Med (1995) 1.61
Agreement in measuring socio-economic status: area-based versus individual measures. Chronic Dis Can (2000) 1.61
Effect of athletic training on exercise cardiac output. J Appl Physiol (1966) 1.59
Expression of IL-12 and IL-13 mRNA in asthma and their modulation in response to steroid therapy. Am J Respir Crit Care Med (1997) 1.58
Respiratory pressures and function in young adults. Am Rev Respir Dis (1983) 1.58
Inhaled corticosteroids: impact on asthma morbidity and mortality. J Allergy Clin Immunol (2001) 1.57
Distribution of pulmonary perfusion in erect man. J Appl Physiol (1966) 1.57
W2H: WWW interface to the GCG sequence analysis package. Bioinformatics (1998) 1.56
The relationship between respiratory impairment and asbestos-related pleural abnormality in an active work force. Am Rev Respir Dis (1990) 1.56
Effects of air pollution on emergency room visits for respiratory illnesses in Montreal, Quebec. Am J Respir Crit Care Med (1997) 1.56
Regular beta-adrenergic agonists. Evidence, not reassurance, is what is needed. Chest (1994) 1.55
Childhood asthma in New Zealand. Br J Dis Chest (1987) 1.54
"Closing volume" and its relationship to gas exchange in seated and supine positions. J Appl Physiol (1971) 1.54
Regular inhaled beta agonist in asthma: effects on exacerbations and lung function. Thorax (1993) 1.53
Low-dose inhaled corticosteroids and the risk of acute myocardial infarction in COPD. Eur Respir J (2005) 1.53
Asbestos-related diseases of the lungs and pleura: current clinical issues. Am Rev Respir Dis (1982) 1.53
Health care utilization in males with obstructive sleep apnea syndrome two years after diagnosis and treatment. Sleep (1999) 1.53